Recent ELAB News
- Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity • GlobeNewswire Inc. • 05/02/2024 12:30:00 PM
- Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare • GlobeNewswire Inc. • 05/01/2024 08:00:00 PM
- Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments • GlobeNewswire Inc. • 05/01/2024 01:00:00 PM
- Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments • GlobeNewswire Inc. • 04/29/2024 01:45:37 PM
- ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results • GlobeNewswire Inc. • 03/29/2024 04:00:00 PM
- Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market • InvestorsHub NewsWire • 03/18/2024 12:51:03 PM
- ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office • GlobeNewswire Inc. • 01/24/2024 01:30:00 PM
- ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach • InvestorsHub NewsWire • 01/17/2024 02:07:02 PM
- ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach • GlobeNewswire Inc. • 01/17/2024 01:30:00 PM
- ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology • InvestorsHub NewsWire • 01/16/2024 03:05:05 PM
- ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology • GlobeNewswire Inc. • 01/16/2024 01:30:00 PM
- ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences • GlobeNewswire Inc. • 01/02/2024 02:15:00 PM
- Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 12/11/2023 02:15:00 PM
- ELEVAI Labs, Inc. Expands International Distribution into Europe • GlobeNewswire Inc. • 12/07/2023 02:41:56 PM
- Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products • GlobeNewswire Inc. • 11/29/2023 02:00:00 PM
- ELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public Offering • PR Newswire (US) • 11/24/2023 06:38:00 PM
- Univest Securities, LLC Announces Closing of $6 Million Initial Public Offering of Common Stock for its Client ELEVAI Labs Inc. (Nasdaq: ELAB) • GlobeNewswire Inc. • 11/24/2023 05:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM